Gordon, G W
Monge, J
Channon, M B
Wu, Q
Skulan, J L
Anbar, A D
Fonseca, R
Article History
First Online: 12 June 2014
Competing interests
: Drs Gordon, Skulan and Anbar have pending patent applications for ‘Isotopic biomarkers for rapid assessment of bone mineral balance in biomedical applications’ (US Application #PCT/US2011/039780; AzTE reference number M10-102L) and ‘Application of Ca isotope analysis to the early detection of metastatic cancer’ (AzTE reference number M13-117) from ASU and AZTE. Dr Fonseca has a patent for ‘Prognostication of MM based on genetic categorization of the disease’ and has received consulting fees from Medtronic, Otsuka, Celgene, Genzyme, BMS, Lilly, Onyx, Binding Site, Millennium and AMGEN; and has sponsored research from Cylene and Onyx.